Table 5.
Study | # Eyes | Intervention | Control | Follow up | Key outcomes |
---|---|---|---|---|---|
Ramezani 2006 | 27 eyes | 4 mg | Natural history | 4 months | Compared to natural history, VA and central macular thickness of treated CRVO was significantly improved at 1 and 2 months respectively No significant difference in occurrence of neovascularisation of iris in both groups |
CRVO: central retinal vein occlusion
VA: visual acuity